Published in J Virol on August 01, 1993
Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol (1998) 2.97
Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase. J Virol (1999) 2.93
Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J Virol (1995) 2.13
The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors. Proc Natl Acad Sci U S A (1996) 2.09
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol (1997) 2.06
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats. J Virol (1994) 1.86
Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol (1999) 1.84
Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J Virol (1994) 1.73
ICP22 and the UL13 protein kinase are both required for herpes simplex virus-induced modification of the large subunit of RNA polymerase II. J Virol (1999) 1.73
Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J Virol (1994) 1.66
A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J (1997) 1.65
Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J Virol (1995) 1.63
Herpes simplex virus type 1 and bovine herpesvirus 1 latency. Clin Microbiol Rev (2003) 1.62
Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol (1996) 1.56
Integrase, LEDGF/p75 and HIV replication. Cell Mol Life Sci (2008) 1.50
Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol (1995) 1.48
Repression of host RNA polymerase II transcription by herpes simplex virus type 1. J Virol (1997) 1.46
Physical interaction between the herpes simplex virus type 1 immediate-early regulatory proteins ICP0 and ICP4. J Virol (1994) 1.45
Association of herpes simplex virus type 1 ICP8 and ICP27 proteins with cellular RNA polymerase II holoenzyme. J Virol (2002) 1.43
Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol (1996) 1.40
Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA. J Virol (1995) 1.32
The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter. Mol Cell Biol (1994) 1.29
Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter. Proc Natl Acad Sci U S A (1993) 1.25
Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J Virol (1994) 1.22
TFIIB-directed transcriptional activation by the orphan nuclear receptor hepatocyte nuclear factor 4. Mol Cell Biol (1996) 1.20
Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication. J Virol (1996) 1.17
Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol Cell Biol (1995) 1.17
Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. J Virol (1995) 1.11
Binding of ICP4, TATA-binding protein, and RNA polymerase II to herpes simplex virus type 1 immediate-early, early, and late promoters in virus-infected cells. J Virol (2007) 1.11
Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27. J Virol (1995) 1.10
Human Nopp140, which interacts with RNA polymerase I: implications for rRNA gene transcription and nucleolar structural organization. Mol Cell Biol (1999) 1.10
Herpes simplex virus immediate-early proteins ICP0 and ICP4 activate the endogenous human alpha-globin gene in nonerythroid cells. J Virol (1997) 1.10
The histone acetyltransferase CLOCK is an essential component of the herpes simplex virus 1 transcriptome that includes TFIID, ICP4, ICP27, and ICP22. J Virol (2011) 1.09
RNA polymerase II holoenzyme modifications accompany transcription reprogramming in herpes simplex virus type 1-infected cells. J Virol (2001) 1.09
Herpes simplex virus type 1 ICP4 promotes transcription preinitiation complex formation by enhancing the binding of TFIID to DNA. J Virol (2000) 1.08
Functional interaction and colocalization of the herpes simplex virus 1 major regulatory protein ICP4 with EAP, a nucleolar-ribosomal protein. Proc Natl Acad Sci U S A (1996) 1.08
Transcriptional trans activation by human immunodeficiency virus type 1 Tat requires specific coactivators that are not basal factors. J Virol (1995) 1.08
Towards an understanding of the herpes simplex virus type 1 latency-reactivation cycle. Interdiscip Perspect Infect Dis (2010) 1.05
DNA-dependent transregulation by IE1 of Autographa californica nuclear polyhedrosis virus: IE1 domains required for transactivation and DNA binding. J Virol (1997) 1.05
The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia. J Virol (1998) 1.04
Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4. J Virol (1996) 1.04
Herpes simplex virus type 1 ICP27-dependent activation of NF-kappaB. J Virol (2006) 1.03
Identification of a novel transcriptional repressor encoded by human cytomegalovirus. J Virol (2001) 1.02
The initiator element in a herpes simplex virus type 1 late-gene promoter enhances activation by ICP4, resulting in abundant late-gene expression. J Virol (2002) 1.02
Identification and characterization of a nucleolar phosphoprotein, Nopp140, as a transcription factor. Mol Cell Biol (1997) 1.01
cis elements that contribute to geminivirus transcriptional regulation and the efficiency of DNA replication. J Virol (1997) 1.01
Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter. J Virol (1995) 1.00
Herpes simplex virus 1 ICP4 forms complexes with TFIID and mediator in virus-infected cells. J Virol (2011) 1.00
Differential cellular requirements for activation of herpes simplex virus type 1 early (tk) and late (gC) promoters by ICP4. J Virol (2004) 0.99
Roscovitine inhibits activation of promoters in herpes simplex virus type 1 genomes independently of promoter-specific factors. J Virol (2004) 0.98
Conserved interaction of the papillomavirus E2 transcriptional activator proteins with human and yeast TFIIB proteins. J Virol (1997) 0.98
Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated? Future Microbiol (2011) 0.97
Characterization of the trans-activation properties of equine herpesvirus 1 EICP0 protein. J Virol (2000) 0.97
Mutational analysis of varicella-zoster virus major immediate-early protein IE62. Nucleic Acids Res (1995) 0.96
Phosphorylation of transcription factor Sp1 during herpes simplex virus type 1 infection. J Virol (2002) 0.96
Repression of the alpha0 gene by ICP4 during a productive herpes simplex virus infection. J Virol (1996) 0.92
Murine cytomegalovirus protein pM79 is a key regulator for viral late transcription. J Virol (2013) 0.92
Herpes simplex virus type 1 ICP0 protein mediates activation of adeno-associated virus type 2 rep gene expression from a latent integrated form. J Virol (2004) 0.92
Heparanase is a host enzyme required for herpes simplex virus-1 release from cells. Nat Commun (2015) 0.92
A mechanism for negative gene regulation in Autographa californica multinucleocapsid nuclear polyhedrosis virus. J Virol (1997) 0.90
Interaction of the equine herpesvirus 1 EICP0 protein with the immediate-early (IE) protein, TFIIB, and TBP may mediate the antagonism between the IE and EICP0 proteins. J Virol (2003) 0.89
Mapping the sequences that mediate interaction of the equine herpesvirus 1 immediate-early protein and human TFIIB. J Virol (2001) 0.88
Identification of a promoter-specific transactivation domain in the herpes simplex virus regulatory protein ICP4. J Virol (1997) 0.87
Noncoding RNPs of viral origin. Cold Spring Harb Perspect Biol (2011) 0.86
DNA-dependent oligomerization of herpes simplex virus type 1 regulatory protein ICP4. J Virol (2007) 0.86
The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. Protein Cell (2012) 0.85
Temperature-dependent conformational changes in herpes simplex virus ICP4 that affect transcription activation. J Virol (2003) 0.85
Induction of transcription by a viral regulatory protein depends on the relative strengths of functional TATA boxes. Mol Cell Biol (1995) 0.85
Requirement of the N-terminal activation domain of herpes simplex virus ICP4 for viral gene expression. J Virol (2012) 0.84
Stabilized binding of TBP to the TATA box of herpes simplex virus type 1 early (tk) and late (gC) promoters by TFIIA and ICP4. J Virol (2008) 0.84
Identification of functional domains of the IR2 protein of equine herpesvirus 1 required for inhibition of viral gene expression and replication. Virology (2011) 0.83
Strong transcriptional activators isolated from viral DNA by the 'activator trap', a novel selection system in mammalian cells. Nucleic Acids Res (1994) 0.83
HSV-1 miR-H6 inhibits HSV-1 replication and IL-6 expression in human corneal epithelial cells in vitro. Clin Dev Immunol (2012) 0.82
HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part I. HSV-1 structure, replication and pathogenesis. Neoplasia (1999) 0.81
Penaeus monodon TATA box-binding protein interacts with the white spot syndrome virus transactivator IE1 and promotes its transcriptional activity. J Virol (2011) 0.81
Barrier to auto integration factor becomes dephosphorylated during HSV-1 Infection and Can Act as a host defense by impairing viral DNA replication and gene expression. PLoS One (2014) 0.80
The N terminus and C terminus of herpes simplex virus 1 ICP4 cooperate to activate viral gene expression. J Virol (2012) 0.80
Bovine Herpes Virus 1 (BHV-1) and Herpes Simplex Virus Type 1 (HSV-1) Promote Survival of Latently Infected Sensory Neurons, in Part by Inhibiting Apoptosis. J Cell Death (2013) 0.79
Analysis of herpes simplex virion tegument ICP4 derived from infected cells and ICP4-expressing cells. PLoS One (2013) 0.79
Identification of a motif in the C terminus of herpes simplex virus regulatory protein ICP4 that contributes to activation of transcription. J Virol (2002) 0.78
ICP4-induced miR-101 attenuates HSV-1 replication. Sci Rep (2016) 0.77
A new paradigm for transcription factor TFIIB functionality. Sci Rep (2014) 0.77
Characterization of herpes simplex virus 2 primary microRNA Transcript regulation. J Virol (2015) 0.77
Characterization of cis-acting elements required for autorepression of the equine herpesvirus 1 IE gene. Virus Res (2012) 0.76
The intrinsic disorder alphabet. III. Dual personality of serine. Intrinsically Disord Proteins (2015) 0.75
Full trans-activation mediated by the immediate-early protein of equine herpesvirus 1 requires a consensus TATA box, but not its cognate binding sequence. Virus Res (2015) 0.75
Characterization of the Dynamic Transcriptome of a Herpesvirus with Long-read Single Molecule Real-Time Sequencing. Sci Rep (2017) 0.75
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res (1983) 124.30
Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J Virol (1974) 26.25
Transcriptional control signals of a eukaryotic protein-coding gene. Science (1982) 25.38
Regulation of alpha genes of herpes simplex virus: expression of chimeric genes produced by fusion of thymidine kinase with alpha gene promoters. Cell (1981) 11.62
Regulation of herpesvirus macromolecular synthesis: sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc Natl Acad Sci U S A (1975) 11.52
Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J Virol (1979) 11.34
Fine-structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J Virol (1980) 9.30
Five intermediate complexes in transcription initiation by RNA polymerase II. Cell (1989) 9.22
Identification of herpes simplex virus DNA sequences which encode a trans-acting polypeptide responsible for stimulation of immediate early transcription. J Mol Biol (1984) 8.87
Mechanism of transcriptional activation by Sp1: evidence for coactivators. Cell (1990) 8.18
Evidence for a direct role for both the 175,000- and 110,000-molecular-weight immediate-early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J Virol (1985) 7.39
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J (1984) 7.33
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID. Nature (1990) 7.11
Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J Virol (1985) 6.67
Mechanism of action of an acidic transcriptional activator in vitro. Cell (1991) 6.04
Adenovirus promoters and E1A transactivation. Annu Rev Genet (1986) 5.86
Cooperative binding of lambda repressors to sites separated by integral turns of the DNA helix. Cell (1986) 5.81
Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions. Mol Cell Biol (1985) 5.76
Deletion mutants in the gene encoding the herpes simplex virus type 1 immediate-early protein ICP0 exhibit impaired growth in cell culture. J Virol (1987) 5.71
Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J Virol (1985) 5.63
Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc Natl Acad Sci U S A (1985) 5.40
Activation of the SV40 late promoter: direct effects of T antigen in the absence of viral DNA replication. Cell (1984) 5.30
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol (1985) 4.74
Separation and characterization of factors mediating accurate transcription by RNA polymerase II. J Biol Chem (1982) 4.71
Functional domains and upstream activation properties of cloned human TATA binding protein. Science (1990) 4.67
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor. Cell (1991) 4.66
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res (1986) 4.55
Cloning of a transcriptionally active human TATA binding factor. Science (1990) 4.18
Characterization of transcription-deficient temperature-sensitive mutants of herpes simplex virus type 1. Virology (1978) 3.87
Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complex. Mol Cell Biol (1990) 3.72
Cloning of a human gene encoding the general transcription initiation factor IIB. Nature (1991) 3.67
Alpha 4, the major regulatory protein of herpes simplex virus type 1, is stably and specifically associated with promoter-regulatory domains of alpha genes and of selected other viral genes. Proc Natl Acad Sci U S A (1986) 3.64
A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. Genes Dev (1992) 3.44
Highly conserved core domain and unique N terminus with presumptive regulatory motifs in a human TATA factor (TFIID). Nature (1990) 3.42
Factors involved in specific transcription by mammalian RNA polymerase II. Purification and functional analysis of initiation factors IIB and IIE. J Biol Chem (1987) 3.38
Isolation and characterization of a large molecular-weight polypeptide of herpes simplex virus type 1. Virology (1974) 3.32
Activation of early adenovirus transcription by the herpesvirus immediate early gene: evidence for a common cellular control factor. Proc Natl Acad Sci U S A (1982) 3.29
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interaction. Genes Dev (1991) 3.24
Transcriptional trans-activation by the human papillomavirus type 16 E2 gene product. J Virol (1987) 3.24
Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J Virol (1988) 3.14
Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Res (1986) 3.09
Binding of the herpes simplex virus immediate-early gene product ICP4 to its own transcription start site. J Virol (1987) 3.09
Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res (1987) 2.99
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID. Proc Natl Acad Sci U S A (1991) 2.95
DNA-binding site of major regulatory protein alpha 4 specifically associated with promoter-regulatory domains of alpha genes of herpes simplex virus type 1. Proc Natl Acad Sci U S A (1986) 2.85
A genetic approach to promoter recognition during trans induction of viral gene expression. Science (1986) 2.77
The DNA-binding properties of the major regulatory protein alpha 4 of herpes simplex viruses. Science (1988) 2.69
The pseudorabies immediate early protein stimulates in vitro transcription by facilitating TFIID: promoter interactions. Genes Dev (1988) 2.60
Regulation of herpes simplex virus 1 genes: alpha gene sequence requirements for transient induction of indicator genes regulated by beta or late (gamma 2) promoters. Virology (1986) 2.56
ATP enhances the binding of simian virus 40 large T antigen to the origin of replication. J Virol (1987) 2.43
Comparison of upstream sequence requirements for positive and negative regulation of a herpes simplex virus immediate-early gene by three virus-encoded trans-acting factors. J Virol (1987) 2.27
Adenovirus E1A protein paradigm viral transactivator. Annu Rev Genet (1989) 2.23
DNA-binding properties of a herpes simplex virus immediate early protein. J Virol (1982) 2.17
Promoter domains required for expression of plasmid-borne copies of the herpes simplex virus thymidine kinase gene in virus-infected mouse fibroblasts and microinjected frog oocytes. Mol Cell Biol (1985) 2.09
Mutational dissection of the HSV-1 immediate-early protein Vmw175 involved in transcriptional transactivation and repression. Virology (1988) 2.03
The regions of the herpes simplex virus type 1 immediate early protein Vmw175 required for site specific DNA binding closely correspond to those involved in transcriptional regulation. Nucleic Acids Res (1988) 1.78
Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes. Nucleic Acids Res (1987) 1.68
Association of herpes simplex virus regulatory protein ICP4 with sequences spanning the ICP4 gene transcription initiation site. Nucleic Acids Res (1988) 1.60
The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection. J Virol (1992) 1.51
Functional relevance of specific interactions between herpes simplex virus type 1 ICP4 and sequences from the promoter-regulatory domain of the viral thymidine kinase gene. J Virol (1990) 1.44
Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J Virol (1991) 1.37
Substitution of a TATA box from a herpes simplex virus late gene in the viral thymidine kinase promoter alters ICP4 inducibility but not temporal expression. J Virol (1992) 1.27
A predictive model for DNA recognition by the herpes simplex virus protein ICP4. J Mol Biol (1991) 1.25
trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol (1990) 1.20
A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties. J Virol (1991) 1.19
A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J Gen Virol (1990) 1.19
Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol (1985) 8.12
Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol (1988) 5.84
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
Rapid assessment of literacy levels of adult primary care patients. Fam Med (1991) 5.04
Activation of immediate-early, early, and late promoters by temperature-sensitive and wild-type forms of herpes simplex virus type 1 protein ICP4. Mol Cell Biol (1985) 4.74
Temperature-sensitive mutants in herpes simplex virus type 1 ICP4 permissive for early gene expression. J Virol (1984) 3.76
Linker-insertion nonsense and restriction-site deletion mutations of the gB glycoprotein gene of herpes simplex virus type 1. J Virol (1987) 3.51
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses. J Virol (1993) 3.46
Nucleotide sequence specifying the glycoprotein gene, gB, of herpes simplex virus type 1. Virology (1984) 3.34
Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res (1987) 2.99
Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol (1998) 2.97
Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: mutations affecting rate of virus entry and cell fusion. Virology (1984) 2.95
The standardization of terminology of lower urinary tract function. J Urol (1979) 2.82
Mutations in herpes simplex virus type 1 genes encoding VP5 and VP23 abrogate capsid formation and cleavage of replicated DNA. J Virol (1993) 2.79
Guidelines for the ethical conduct of medical research involving children. Royal College of Paediatrics, Child Health: Ethics Advisory Committee. Arch Dis Child (2000) 2.57
Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function. J Virol (1999) 2.32
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein. J Virol (1994) 2.17
Herpes simplex virus type 1 VP26 is not essential for replication in cell culture but influences production of infectious virus in the nervous system of infected mice. Virology (1998) 2.17
Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J Virol (1995) 2.10
Anaemia and mortality in calves infested with the long-nosed sucking louse (Linognathus vituli). Vet Rec (2003) 2.07
The herpes simplex virus immediate-early protein ICP0 affects transcription from the viral genome and infected-cell survival in the absence of ICP4 and ICP27. J Virol (1997) 2.06
A system for tissue-specific gene targeting: transgenic mice susceptible to subgroup A avian leukosis virus-based retroviral vectors. Proc Natl Acad Sci U S A (1994) 1.99
Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science (1990) 1.93
Receptor-triggered membrane association of a model retroviral glycoprotein. Proc Natl Acad Sci U S A (1998) 1.91
Perturbation of cell cycle progression and cellular gene expression as a function of herpes simplex virus ICP0. J Virol (1999) 1.84
Sex ratio at birth in China, with reference to other areas in East Asia: what we know. Asia Pac Popul J (1995) 1.83
Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol Cell Biol (1996) 1.56
Identification of osteoblast/osteocyte factor 45 (OF45), a bone-specific cDNA encoding an RGD-containing protein that is highly expressed in osteoblasts and osteocytes. J Biol Chem (2000) 1.52
The effectiveness of interpersonal skills training on the social skill acquisition of moderately and mildly retarded adults. J Appl Behav Anal (1980) 1.50
Functional interactions between herpes simplex virus immediate-early proteins during infection: gene expression as a consequence of ICP27 and different domains of ICP4. J Virol (1995) 1.48
Double cos site vectors: simplified cosmid cloning. Methods Enzymol (1987) 1.44
Functional relevance of specific interactions between herpes simplex virus type 1 ICP4 and sequences from the promoter-regulatory domain of the viral thymidine kinase gene. J Virol (1990) 1.44
Hypoxia-induced increase in soluble Flt-1 production correlates with enhanced oxidative stress in trophoblast cells from the human placenta. Placenta (2005) 1.42
Role of basic residues in the subgroup-determining region of the subgroup A avian sarcoma and leukosis virus envelope in receptor binding and infection. J Virol (1997) 1.40
Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J Virol (1996) 1.40
Chewing lice, sheep scab and systemic endectocides. Vet Rec (1999) 1.39
Herpes simplex virus transactivator ICP4 operationally substitutes for the cellular transcription factor Sp1 for efficient expression of the viral thymidine kinase gene. J Virol (1991) 1.37
Gene transfer to neurons using herpes simplex virus-based vectors. Annu Rev Neurosci (1996) 1.35
Soluble receptor-induced retroviral infection of receptor-deficient cells. J Virol (2000) 1.33
Triphalangeal thumb-polysyndactyly syndrome and syndactyly type IV are caused by genomic duplications involving the long range, limb-specific SHH enhancer. J Med Genet (2008) 1.33
Characterization of determinants for envelope binding and infection in tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol (1998) 1.31
Substitution of a TATA box from a herpes simplex virus late gene in the viral thymidine kinase promoter alters ICP4 inducibility but not temporal expression. J Virol (1992) 1.27
Activities of heterodimers composed of DNA-binding- and transactivation-deficient subunits of the herpes simplex virus regulatory protein ICP4. J Virol (1991) 1.27
Herpes simplex virus infected cell polypeptide 4 preferentially represses Sp1-activated over basal transcription from its own promoter. Proc Natl Acad Sci U S A (1993) 1.25
The role of ICP4 repressor activity in temporal expression of the IE-3 and latency-associated transcript promoters during HSV-1 infection. Virology (1994) 1.23
Development and application of herpes simplex virus vectors for human gene therapy. Annu Rev Microbiol (1995) 1.22
The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes. J Virol (1989) 1.22
Production and characterization of a soluble, active form of Tva, the subgroup A avian sarcoma and leukosis virus receptor. J Virol (1999) 1.21
trans-dominant inhibition of herpes simplex virus transcriptional regulatory protein ICP4 by heterodimer formation. J Virol (1990) 1.20
Intragenic complementation among partial peptides of herpes simplex virus regulatory protein ICP4. J Virol (1989) 1.20
A second-site revertant of a defective herpes simplex virus ICP4 protein with restored regulatory activities and impaired DNA-binding properties. J Virol (1991) 1.19
Son preference and the sex ratio at birth in China: a provincial level analysis. Soc Biol (1997) 1.19
Efficient activation of viral genomes by levels of herpes simplex virus ICP0 insufficient to affect cellular gene expression or cell survival. J Virol (2001) 1.17
Role of protein kinase A and the serine-rich region of herpes simplex virus type 1 ICP4 in viral replication. J Virol (1996) 1.17
Repression of activator-mediated transcription by herpes simplex virus ICP4 via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol Cell Biol (1995) 1.17
Efficient infection mediated by viral receptors incorporated into retroviral particles. J Virol (1998) 1.14
Conversion of a human low-density lipoprotein receptor ligandbinding repeat to a virus receptor: identification of residues important for ligand specificity. Proc Natl Acad Sci U S A (1998) 1.13
Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol (1990) 1.13
Relationship between TATA-binding protein and herpes simplex virus type 1 ICP4 DNA-binding sites in complex formation and repression of transcription. J Virol (1995) 1.11
Herpes simplex virus for gene delivery to neurons. New Biol (1991) 1.05
The polyserine tract of herpes simplex virus ICP4 is required for normal viral gene expression and growth in murine trigeminal ganglia. J Virol (1998) 1.04
Regulation of beta-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor alpha. Neurochem Int (2001) 1.04
Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4. J Virol (1996) 1.04
A study of low pH-induced refolding of Env of avian sarcoma and leukosis virus into a six-helix bundle. Biophys J (2004) 1.03
Rhizobium meliloti and Rhizobium leguminosarum dctD gene products bind to tandem sites in an activation sequence located upstream of sigma 54-dependent dctA promoters. J Bacteriol (1990) 1.01
Anisotropic two-dimensional electron gas at the LaAlO₃/SrTiO₃ (110) interface. Nat Commun (2013) 1.01
Adsorption and desorption of natural organic matter on iron oxide: mechanisms and models. Environ Sci Technol (1994) 1.01
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab (2006) 0.99
Disproportionate growth in mice with Igf-2 transgenes. Proc Natl Acad Sci U S A (1994) 0.96
Water quality trends at inflows to Everglades National Park, 1977-2005. J Environ Qual (2010) 0.94
The search for reinforcers to train and maintain effective parent behviors. Rehabil Lit (1977) 0.91
Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0. Virology (1999) 0.91
P2Y(11) receptor expression by human lymphocytes: evidence for two cAMP-linked purinoceptors. Eur J Pharmacol (2001) 0.90
Interpretation of pediatric lung function: impact of ethnicity. Pediatr Pulmonol (2012) 0.89
Self-management programmes with mentally retarded workers: implications for developing independent vocational behaviour. Br J Soc Clin Psychol (1978) 0.89
Sex ratio of China's population deserves attention. China Popul Today (1992) 0.88
Genomic regions regulating imprinting and insulin-like growth factor-II promoter 3 activity in transgenics: novel enhancer and silencer elements. Genes Funct (1997) 0.88
Threat to medical confidentiality. Lancet (1983) 0.87
[Effects of hepatitis B virus X gene on apoptosis and the activity of telomerase in HepG(2) cells]. Zhonghua Gan Zang Bing Za Zhi (2000) 0.86
Mutational analysis of the subgroup A avian sarcoma and leukosis virus putative fusion peptide domain. J Virol (2000) 0.85
High plasma insulin-like growth factor-II and low lipid content in transgenic mice: measurements of lipid metabolism. J Endocrinol (1994) 0.85
Induction of transcription by a viral regulatory protein depends on the relative strengths of functional TATA boxes. Mol Cell Biol (1995) 0.85
Enhanced levels of radiation-induced G2 phase delay in ataxia telangiectasia heterozygotes. Cancer Genet Cytogenet (1992) 0.85
Shin splints--a literature review. Br J Sports Med (1985) 0.84
The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene (1996) 0.83
Cutaneous and systemic responses during primary and challenge infestations of sheep with the sheep scab mite, Psoroptes ovis. Parasite Immunol (2000) 0.83
Effects of burn temperature on ash nutrient forms and availability from cattail (Typha domingensis) and sawgrass (Cladium jamaicense) in the Florida Everglades. J Environ Qual (2009) 0.83
Initiator elements and regulated expression of the herpes simplex virus thymidine kinase gene. J Virol (1995) 0.82
Behavior management with the mentally retarded: an empirical analysis of the research. Ment Retard (1977) 0.81
Attempts to immunize sheep against the scab mite, Psoroptes ovis. Parasite Immunol (2002) 0.81
A comprehensive discussion of the birth gender ratio in China. Chin J Popul Sci (1994) 0.81
Design and application of HSV vectors for neuroprotection. Gene Ther (2000) 0.81